Milestone Scientific (NYSEAMERICAN:MLSS) issued its earnings results on Tuesday. The medical instruments supplier reported ($0.01) earnings per share for the quarter, beating the consensus estimate of ($0.02) by $0.01, MarketWatch Earnings reports. Milestone Scientific had a negative net margin of 165.06% and a negative return on equity of 104.43%.
NYSEAMERICAN:MLSS opened at $3.72 on Friday. The firm has a market capitalization of $236.94 million, a price-to-earnings ratio of -23.25 and a beta of 1.54. Milestone Scientific has a 12 month low of $0.85 and a 12 month high of $4.85. The company has a 50-day moving average price of $1.89.
Separately, Zacks Investment Research upgraded shares of Milestone Scientific from a “hold” rating to a “buy” rating and set a $4.25 target price on the stock in a research report on Wednesday, March 24th.
Milestone Scientific Company Profile
Milestone Scientific, Inc develops computer-controlled anesthetic delivery devices for the medical and dental markets in the United States and internationally. The company operates in two segments, Dental and Medical. Its products include CompuDent System that are used to control the flow rate of the anesthesia during the injection, which allows virtually painless injections for various dental procedures, including routine fillings, implants, root canals, and crowns.
Featured Story: Differences Between Momentum Investing and Long Term Investing
Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.